Moderna on Wednesday reported positive early results for its booster shot against new variants of the COVID-19 strains B.1.351 and P.1, which have been identified in South Africa and Brazil, in an ongoing clinical trial. According to CNBC, Moderna CEO Stephane Bancel said,…
Source: News Max

 16 total views,  1 views today

Leave a Reply